ADVFN US – Market Content Editor
-
Paychex Reports Q4 Results In Line with Estimates, Stock Dips
Paychex Inc. (NASDAQ:PAYX) shares slipped 2.8% in premarket trading Wednesday after the HR services provider posted fourth-quarter financial results that met analyst expectations on both revenue and earnings. The company reported adjusted diluted earnings per share (EPS) of $1.19 for the quarter, exactly matching consensus forecasts. Revenue came in at $1.43 billion, representing a solid…
-
ECARX Shares Surge Following Collaboration with Robotic Lawn Mower Innovator
ECARX Holdings Inc. (NASDAQ:ECX) stock jumped 9% in pre-market trading Wednesday after the mobility technology company revealed a new partnership to integrate its lidar systems into robotic lawn mowers. The deal with a prominent yet unnamed global developer of robotic lawn mowers signals ECARX’s strategic move to broaden its reach beyond automotive intelligence into the…
-
AgEagle Aerial Systems Shares Climb on Increased Drone Sales in South Korea
AgEagle Aerial Systems Inc. (NYSE:UAVS) saw its stock rise by 2% following the announcement of two additional eBee X drone sales in South Korea. This sale pushes the total number of AgEagle’s eBee drones operating in the country to over 100 units. The eBee X, a leading fixed-wing drone built for precise geospatial data gathering,…
-
Contineum Therapeutics Shares Drop After Delay in Trial Data Release
Contineum Therapeutics Inc (NASDAQ:CTNM) experienced an 8.4% decline in its stock price following the announcement of a delay in releasing topline results from its Phase 1b study of PIPE-791. The biopharmaceutical company, currently in the clinical stage, completed enrolling both healthy volunteers and patients with progressive multiple sclerosis (PrMS) for the trial. However, it now…
-
Bumble Shares Jump After Company Announces 30% Staff Reduction
Bumble (NASDAQ:BMBL) shares climbed 13% following the company’s announcement of plans to cut approximately 240 jobs worldwide, amounting to about 30% of its workforce. In a regulatory filing, Bumble revealed that its Board of Directors approved the layoffs on June 23, 2025, aiming to “realign its operating structure to better focus on strategic priorities.” The…
-
Tesla’s European Sales Decline Amid Rising Competition from Chinese EV Brands
Tesla (NASDAQ:TSLA) experienced a significant 27.9% drop in new vehicle sales across Europe in May compared to the previous year, even as fully electric vehicle sales surged 27.2% in the region. The American electric carmaker’s market share in Europe shrank to 1.2% in May from 1.8% a year earlier, marking the fifth straight month of…
-
Allot Shares Drop After Pricing Public Offering at $8 per Share
Shares of Allot Ltd. (NASDAQ:ALLT) declined by 13% following the announcement of its underwritten public offering priced at $8.00 per share, marking a steep discount compared to the previous close of $9.61. The company, which specializes in network intelligence and security solutions, is offering 5 million ordinary shares, with an additional option for underwriters to…
-
General Mills Predicts Decline in Annual Earnings Amid Difficult Market Conditions
General Mills (NYSE: GIS) has issued a cautionary forecast for its current fiscal year, highlighting weak category sales growth and a decline in income as the company navigates challenges from tariff-related cost pressures. The packaged foods leader, known for brands like Cheerios and Chex, is feeling the impact of consumers tightening their budgets amid ongoing…
-
AST SpaceMobile Shares Drop Following $225 Million Convertible Note Buyback
AST SpaceMobile (NASDAQ:ASTS) shares declined by 7.75% after the company revealed plans to repurchase $225 million of its convertible notes due 2032 and to raise funds through a registered direct offering of common stock. The company will buy back $225 million of its 4.25% convertible notes maturing in 2032 via private deals with select noteholders.…
-
Precision BioSciences Shares Surge Following FDA Rare Pediatric Disease Designation
Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) jumped 17% on Wednesday after the company announced that its gene therapy candidate, PBGENE-DMD, received the Rare Pediatric Disease Designation from the U.S. Food and Drug Administration (FDA). This special designation recognizes the urgent need for innovative treatments for Duchenne muscular dystrophy (DMD), a rare genetic condition that primarily…